Skip to main content
Clinical Trials/CTRI/2023/06/053734
CTRI/2023/06/053734
Not yet recruiting
Phase 3

se of transcutaneous electric nerve stimulation for treatment of restless leg syndrome in chronic liver disease patients

Dr. Vimal Kumar Paliwal0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G258- Other specified extrapyramidal andmovement disorders
Sponsor
Dr. Vimal Kumar Paliwal
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Vimal Kumar Paliwal

Eligibility Criteria

Inclusion Criteria

  • Patients of Chronic Liver Disease defined by progressive deterioration of liver function over 6
  • months, with age \> 18 years, attending Gastromedicine / Neurology OPD at SGPGI and
  • diagnosed with RLS as defined by the International RLS Study Group with Serum Ferritin \> 75 ng/ ml at presentation or Non improvement of RLS Symptoms after 6 weeks of Intravenous iron therapy in case with Serum Ferritin \< 75 ng/ml.

Exclusion Criteria

  • 1\. Active alcohol intake
  • 2\. Chronic Kidney diseasedefined by eGFR \< 60
  • 3\. Recent Hospitalization / recent clinical worsening ( \< 4 weeks ) for deteriration of liver function of liver function as evidenced by new appearance or worsening of ascites or encephalopathy or jaundice, or reduction of urine output , or gastrointestinal bleeding
  • 4\. Neurological illnesses like epilepsy disorder/ neuropathy / multiple sclerosis / spinal cord diseases 5\. Pregnancy 6\. Patients of rls on ongoing treatment with alpha 2 delta ligands / dopaminergic agonists / opioids . 7\. Localized skin eruptions 8\. Pacemaker

Outcomes

Primary Outcomes

Not specified

Similar Trials